Treating lymphoma or leukemia in a patient comprises modulating the level of an expression product of a gene selected from PI3KR1, GNAS, NESP5, JAK1, neurogranin, HIPK1, or Nrf2

Finn Skou Pedersen (Opfinder), Annette Balle Sørensen (Opfinder), Anne Ahlmann Nielsen (Opfinder), Javier Martin Hernandez (Opfinder), Helle Moving (Opfinder)

Publikation: Patent

OriginalsprogEngelsk
IPCA61K-039/395
PatentnummerUS2007098728-A1
Journaliseringsdato03/05/2007
LandUSA
StatusUdgivet - 2007
Udgivet eksterntJa

Citationsformater